146 related articles for article (PubMed ID: 3276475)
1. Anti-adrenal medullary antibodies in IDDM subjects and subjects at high risk of developing IDDM.
Brown FM; Kamalesh M; Adri MN; Rabinowe SL
Diabetes Care; 1988 Jan; 11(1):30-3. PubMed ID: 3276475
[TBL] [Abstract][Full Text] [Related]
2. Different effects of duration on prevalence of anti-adrenal medullary and pancreatic islet cell antibodies in type I diabetes mellitus.
Brown FM; Vinik AI; Ganda OP; Adri MN; Rabinowe SL
Horm Metab Res; 1989 Aug; 21(8):434-7. PubMed ID: 2676819
[TBL] [Abstract][Full Text] [Related]
3. Anti-sympathetic ganglia antibodies and postural blood pressure in IDDM subjects of varying duration and patients at high risk of developing IDDM.
Rabinowe SL; Brown FM; Watts M; Kadrofske MM; Vinik AI
Diabetes Care; 1989 Jan; 12(1):1-6. PubMed ID: 2653745
[TBL] [Abstract][Full Text] [Related]
4. Complement-fixing antibodies to sympathetic and parasympathetic tissues in IDDM. Autonomic brake index and heart-rate variation.
Rabinowe SL; Brown FM; Watts M; Smith AM
Diabetes Care; 1990 Oct; 13(10):1084-8. PubMed ID: 1698597
[TBL] [Abstract][Full Text] [Related]
5. Anti-sympathetic nervous system autoantibodies. Diminished catecholamines with orthostasis.
Brown FM; Brink SJ; Freeman R; Rabinowe SL
Diabetes; 1989 Jul; 38(7):938-41. PubMed ID: 2737366
[TBL] [Abstract][Full Text] [Related]
6. Islet cell antibodies as predictive markers for IDDM in children with high background incidence of disease.
Karjalainen JK
Diabetes; 1990 Sep; 39(9):1144-50. PubMed ID: 2200731
[TBL] [Abstract][Full Text] [Related]
7. Detection of islet cell surface antibodies using cloned beta cells and comparison of their incidence with that of islet cell cytoplasmic antibodies.
Grant AM; Harrison DE; Moysey L; Smith D; Ashcroft SJ
Diabetes Res; 1985 Sep; 2(5):225-9. PubMed ID: 3905186
[TBL] [Abstract][Full Text] [Related]
8. An association between complement-fixing cytoplasmic islet cell antibodies and endogenous insulin secretion in children with insulin-dependent diabetes mellitus.
Mustonen A; Knip M; Akerblom HK
Diabetes; 1983 Aug; 32(8):743-7. PubMed ID: 6347771
[TBL] [Abstract][Full Text] [Related]
9. Influence of age on the associations among insulin autoantibodies, islet cell antibodies, and HLA DAQ1*0301-DQB1*0302 in siblings of patients with type 1 (insulin-dependent) diabetes mellitus. Belgian Diabetes Registry.
Gorus FK; Vandewalle CL; Dorchy H; Van Crombrugge P; Schuit FC; Pipeleers DG
J Clin Endocrinol Metab; 1994 May; 78(5):1172-8. PubMed ID: 8175975
[TBL] [Abstract][Full Text] [Related]
10. Relation between insulin antibody and complement-fixing islet cell antibody at clinical diagnosis of IDDM.
Karjalainen J; Knip M; Mustonen A; Ilonen J; Akerblom HK
Diabetes; 1986 May; 35(5):620-2. PubMed ID: 3514336
[TBL] [Abstract][Full Text] [Related]
11. Fetal type lymphocytes in insulin dependent diabetes mellitus.
Gyarmati J; Szekeres-Barthó J; Fischer B; Soltész G
Autoimmunity; 1999; 30(2):63-9. PubMed ID: 10435718
[TBL] [Abstract][Full Text] [Related]
12. [Islet cell cytoplasmic antibodies (ICA) and complement-fixing islet cell cytoplasmic antibodies (CF-ICA) in patients with newly detected type 1 diabetes mellitus of short duration].
Majkowska L
Ann Acad Med Stetin; 1990; 36():95-111. PubMed ID: 2099111
[TBL] [Abstract][Full Text] [Related]
13. CD5+ B lymphocytes in high-risk islet cell antibody-positive and newly diagnosed IDDM subjects.
Schatz DA; Lang F; Cantor AB; Riley WJ; Maclaren NK; Sleasman JW; Barrett DJ
Diabetes; 1991 Oct; 40(10):1314-8. PubMed ID: 1718800
[TBL] [Abstract][Full Text] [Related]
14. Prevalence of cytoplasmatic islet cell antibodies and insulin autoantibodies is increased in subjects with genetically defined high risk for insulin-dependent diabetes mellitus.
Kuglin B; Bertrams J; Linke C; Gries FA; Kolb H
Klin Wochenschr; 1989 Jan; 67(2):66-73. PubMed ID: 2646470
[TBL] [Abstract][Full Text] [Related]
15. Relationship between serum insulin autoantibodies, islet cell antibodies and Coxsackie-B4 and mumps virus-specific antibodies at the clinical manifestation of type 1 (insulin-dependent) diabetes.
Karjalainen J; Knip M; Hyöty H; Leinikki P; Ilonen J; Käär ML; Akerblom HK
Diabetologia; 1988 Mar; 31(3):146-52. PubMed ID: 3286341
[TBL] [Abstract][Full Text] [Related]
16. The prevalence of islet cell antibodies in Japanese insulin-dependent and non-insulin-dependent diabetic patients studied by indirect immunofluorescence and by a new method.
Kobayashi T; Sugimoto T; Itoh T; Kosaka K; Tanaka T; Suwa S; Sato K; Tsuji K
Diabetes; 1986 Mar; 35(3):335-40. PubMed ID: 3512344
[TBL] [Abstract][Full Text] [Related]
17. Islet cell and 64K autoantibodies are associated with plasma IgG in newly diagnosed insulin-dependent diabetic children.
Gerling I; Baekkeskov S; Lernmark A
J Immunol; 1986 Dec; 137(12):3782-5. PubMed ID: 3537124
[TBL] [Abstract][Full Text] [Related]
18. Anti-37kDa antibodies are associated with the development of IDDM in individuals with islet cell antibodies.
Ongagna JC; Levy-Marchal C
Diabetologia; 1995 Mar; 38(3):370-5. PubMed ID: 7758886
[TBL] [Abstract][Full Text] [Related]
19. Autoantibodies in Indian-Asians with insulin-dependent diabetes in the UK.
Odugbesan O; Fletcher JA; Sanders A; Bradwell AR; Botazzo GF; Barnett AH
Postgrad Med J; 1988 May; 64(751):357-60. PubMed ID: 3059339
[TBL] [Abstract][Full Text] [Related]
20. [Detection of islet cell antibodies by using avidin-biotin-peroxidase complex technique].
Yang JL; Huang YQ; Yue Y
Zhonghua Nei Ke Za Zhi; 1994 Feb; 33(2):92-4. PubMed ID: 8070298
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
